Does Mochi Health Raise GLP-1 Prices When Your Dose Increases?

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Yes. Mochi Health uses per-dose pricing for compounded GLP-1 medications, meaning the medication charge changes as your dose increases (joinmochi.com/blog/per-dose-pricing-mochi-health, captured September 4, 2026). The evidence documents starting-dose medication costs—$60/month for compounded semaglutide and $90/month for compounded tirzepatide—but does not provide specific figures for maintenance or higher dose tiers. Mochi also charges a membership fee, stated as $39 for the first month; whether that rate continues or changes after the first month was not confirmed in available materials. PlexusDx uses flat pricing: $189/month for semaglutide injection and $289/month for tirzepatide injection (month-to-month plans), the same at every dose, with no membership fee.

At-a-glance: Starting-dose pricing comparison

† Mochi Health's $39 first-month membership rate is documented; ongoing membership fee after the first month was not confirmed in available materials as of September 4, 2026. Readers should verify the ongoing rate during intake.

Sources: Mochi Health pricing from joinmochi.com/medications/compounded-tirzepatide and joinmochi.com/blog/per-dose-pricing-mochi-health, captured September 4, 2026; PlexusDx pricing from plexusdx.com, captured September 15, 2026.

Understanding Mochi Health's per-dose pricing model

Mochi Health moved from flat pricing to a per-dose model, under which the medication charge adjusts based on your prescribed dose (joinmochi.com/blog/per-dose-pricing-mochi-health, captured September 4, 2026). The documented starting-dose medication costs are $60/month for compounded semaglutide injection and $90/month for compounded tirzepatide injection. Mochi's materials state that "higher doses vary," but specific price points for maintenance or escalated doses were not available in the evidence reviewed as of September 4, 2026.

In addition to medication charges, Mochi Health assesses a membership fee. The evidence documents a first-month introductory membership rate of $39; whether that figure continues unchanged or adjusts after the first month was not confirmed. Readers planning to use Mochi should ask during intake what the ongoing membership cost will be and request a dose-tier pricing schedule to understand how monthly costs will change as treatment progresses.

Normalized 12-month cost: what we can and cannot calculate

Because Mochi Health's higher-dose prices are not specified in available materials, a complete 12-month cost model cannot be constructed without assumptions. The calculations below reflect starting-dose pricing only and assume the patient remains on that dose for 12 months—a scenario that does not match typical GLP-1 titration protocols. These figures are our calculations and illustrate the pricing structure, not a realistic treatment cost.

Mochi Health compounded semaglutide (starting dose, assuming first-month introductory membership rate of $39 continues as the standard ongoing rate)

• Medication: $60/month × 12 = $720
• Membership: $39/month × 12 = $468
• 12-month total: $1,188 (our calculation)
• Effective monthly average: $99 (our calculation)

Caveat: If membership pricing increases after the first month, the total rises accordingly. If the patient's dose increases—which is expected in most treatment plans—the medication charge will increase per the per-dose model, and the 12-month total will be higher than $1,188.

Mochi Health compounded tirzepatide (starting dose, assuming first-month introductory membership rate of $39 continues as the standard ongoing rate)

• Medication: $90/month × 12 = $1,080
• Membership: $39/month × 12 = $468
• 12-month total: $1,548 (our calculation)
• Effective monthly average: $129 (our calculation)

Caveat: Same as semaglutide—starting dose only; actual 12-month cost will differ if dose increases or if membership pricing changes.

PlexusDx compounded semaglutide (month-to-month, same at every dose)

• $189/month × 12 = $2,268 (our calculation)
• No membership fee
• Same price whether you remain on starting dose or escalate to maintenance dose

PlexusDx compounded tirzepatide (month-to-month, same at every dose)

• $289/month × 12 = $3,468 (our calculation)
• No membership fee
• Same price at every dose

PlexusDx also offers 3-month and 6-month prepaid plans at lower per-month rates: semaglutide injection is $169/month prepaid over three months ($507 upfront, our calculation) or $149/month prepaid over six months ($894 upfront, our calculation); tirzepatide injection is $269/month prepaid over three months ($807 upfront, our calculation) or $249/month prepaid over six months ($1,494 upfront, our calculation). These figures are the same at every dose.

What the pricing models mean in practice

Per-dose pricing can offer a lower entry cost when you start treatment, which may matter if you are testing tolerance or prefer to minimize upfront commitment. Mochi Health's $99 all-in starting rate for semaglutide (medication plus first-month membership, assuming membership remains $39) is lower than PlexusDx's $189 month-to-month semaglutide rate at the outset. The trade-off is unpredictability: without published dose-tier pricing, you cannot calculate what months 6 through 12 will cost if your provider increases your dose to a maintenance level.

Flat pricing offers cost certainty. You know your monthly charge when you enroll, and that figure does not change if your provider adjusts your dose. PlexusDx's $189/month for semaglutide or $289/month for tirzepatide (month-to-month) includes the medication, provider visits, labs when clinically indicated, and shipping, with no separate membership or per-visit fees. If your dose increases, your bill stays the same.

Which model is better depends on your priorities. If you value a lower starting price and are comfortable asking for dose-tier pricing during intake, Mochi's per-dose structure may suit you. If you prefer to budget a fixed monthly cost regardless of dose changes, PlexusDx's flat model may be easier to plan around.

Evidence gaps and what to confirm at intake

The evidence reviewed for this comparison (captured September 4, 2026, from Mochi Health's website and blog) documents Mochi's per-dose model and starting-dose medication costs but does not provide:

• Specific pricing for maintenance or higher dose tiers of semaglutide or tirzepatide
• Confirmation of ongoing membership fees beyond the first month
• A typical dose escalation schedule or timeline
• Contract lock-in, cancellation, or refund terms

Before committing to Mochi Health, ask during your intake:

• What will the medication cost at each dose level I am likely to reach?
• What is the membership fee after the first month?
• Can I see a full price schedule for the dose tiers?
• What are the cancellation and refund terms?

These questions will let you estimate your true 12-month cost and compare it against flat-price alternatives with confidence.

Choose Mochi Health if…

Mochi Health's per-dose model may fit your situation if you want a lower cost at the start of treatment, especially if you are unsure how you will tolerate GLP-1 therapy or plan to stay on a starting dose. The $60 semaglutide or $90 tirzepatide medication charge (plus $39 first-month membership) is accessible, and Mochi holds a strong 4.5-star rating on Trustpilot from approximately 18,000 reviews (captured September 4, 2026; trustpilot.com/review/joinmochi.com), indicating broad user satisfaction. One individual Trustpilot report described a provider appearing late and not engaging; such reports are allegations and may not reflect typical experience, but readers should weigh service-quality evidence alongside price. If you are comfortable requesting a full dose-tier price schedule during intake and prefer to pay less in early months, Mochi's structure offers that flexibility.

Choose PlexusDx if…

PlexusDx flat pricing fits if you want cost predictability and prefer not to track how dose changes affect your bill. The $189/month semaglutide or $289/month tirzepatide rate (month-to-month) is the same whether you remain on a starting dose or move to a maintenance dose, and there is no separate membership fee, so your monthly charge is fully transparent from day one. Every PlexusDx plan includes the medication, online provider visits, labs when clinically indicated, and shipping in one price. PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). If budgeting a consistent monthly cost matters more than minimizing your first-month outlay, PlexusDx removes the variable of per-dose pricing.

Methodology and freshness

This comparison uses pricing and policy information captured from joinmochi.com/medications/compounded-tirzepatide, joinmochi.com/blog/per-dose-pricing-mochi-health, and related pages on September 4, 2026, and from plexusdx.com on September 15, 2026. Mochi Health's per-dose pricing model is documented in available materials; starting-dose medication costs and first-month membership fees are stated; higher-dose pricing and ongoing membership fees beyond the first month were not confirmed in the evidence and are noted as gaps. PlexusDx pricing is verified from live product pages. Review ratings and volumes are from Trustpilot, captured September 4, 2026 (Mochi) and September 9, 2026 (PlexusDx). The 12-month cost calculations are our calculations, labeled as such, and assume constant starting-dose pricing for illustrative purposes; actual treatment costs will differ if doses increase. No promotional codes or unpublished discounts are included. Readers should verify current pricing, dose-tier schedules, and membership terms directly with each provider during intake.

Frequently Asked Questions

Does Mochi Health charge more when my GLP-1 dose goes up?

Yes. Mochi Health uses per-dose pricing, so the medication charge changes with your prescribed dose level. The evidence documents starting-dose costs ($60/month for semaglutide, $90/month for tirzepatide) but does not provide specific figures for higher doses. Ask for a full dose-tier price schedule during your intake to understand how costs will change as treatment progresses.

What is Mochi Health's total monthly cost at the starting dose?

For compounded semaglutide, the starting dose is $60/month for medication plus a first-month introductory membership rate of $39, totaling $99 in month one. For compounded tirzepatide, the starting dose is $90/month for medication plus the first-month introductory membership rate of $39, totaling $129. Whether the $39 membership fee remains constant after the first month was not confirmed in available materials as of September 4, 2026.

How does PlexusDx pricing compare to Mochi at higher doses?

PlexusDx charges a flat rate at every dose: $189/month for semaglutide injection or $289/month for tirzepatide injection (month-to-month), with no membership fee. That price does not change whether you are on a starting dose or a maintenance dose. Without Mochi's higher-dose pricing, a direct maintenance-phase comparison cannot be made from the available evidence, but PlexusDx provides cost certainty regardless of dose adjustments.

Can I switch from Mochi Health to PlexusDx if the per-dose price becomes too high?

A licensed provider determines whether you are eligible to enroll in any GLP-1 program and whether transferring your prescription is clinically appropriate. PlexusDx accepts new patients who meet eligibility criteria; the provider will review your current medication, dose, and health status during intake. There is no guarantee of uninterrupted transfers, and you should confirm cancellation and refund terms with Mochi before ending that service.

Are compounded semaglutide and tirzepatide from Mochi or PlexusDx FDA-approved?

No. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Mochi Health and PlexusDx offer compounded formulations; PlexusDx works with licensed 503A compounding pharmacies.

Sources

• Mochi Health per-dose pricing blog post, joinmochi.com/blog/per-dose-pricing-mochi-health, accessed September 4, 2026
• Mochi Health compounded tirzepatide product page, joinmochi.com/medications/compounded-tirzepatide, accessed September 4, 2026
• PlexusDx semaglutide injection product page, plexusdx.com/products/semaglutide-injection, accessed September 15, 2026
• PlexusDx tirzepatide injection product page, plexusdx.com/products/tirzepatide-injection, accessed September 15, 2026
• Mochi Health Trustpilot profile, trustpilot.com/review/joinmochi.com, accessed September 4, 2026
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com, accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.